Diabetes, stress-induced aging and Alzheimer's disease, immigration-related obesity, and implantable drug testing devices are the targets of the research awards from the Minnesota Partnership for Biotechnology and Medical Genomics in 2019. The state-funded grants for these team science proposals total nearly $5.2 million. The five teams will initiate collaborative two-year projects that could transform the treatment of diseases that affect Minnesotans. Each team includes investigators from Mayo Clinic and the University of Minnesota.
2019 award-winning projects and awardees
"Generation and Immune Protection of PD-L1 Designer Islets for the Treatment of Type 1 Diabetes"
Brian Fife, University of Minnesota, and Quinn Peterson, Mayo Clinic
"Stress-Induced Exacerbation of Senescence-Associated Diseases"
Alessandro Bartolomucci, University of Minnesota, and Jan van Deursen, Mayo Clinic
"Retinal Hyperspectral Imaging: A Tool for Early Detection of Alzheimer's Disease"
Swati Moore, University of Minnesota, and John Chen, Mayo Clinic
"Targeting the Gut Microbiome to Prevent the Increasing Incidence of Obesity in Immigrant Populations"
Dan Knights, University of Minnesota, and Purna Kashyap, Mayo Clinic
"Defining Parameters and Performance Specifications for an Implantable CNS Drug Testing Device"
William Elmquist, University of Minnesota, and Terence Burns, Mayo Clinic